494
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Budget impact model of a 5-grass sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis

, , , , , & show all
Pages 909-918 | Accepted 09 Jun 2015, Published online: 06 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Abdullah Aburiziza, Mohammed A Almatrafi, Aishah Saud Alonazi, Mawaddah Hani Zatari, Samah Ali Alqouzi, Rasha Abdulaziz Mandili, Wedad Taher Hawsawi & Rehab Hejji Aljohani. (2022) The Prevalence, Clinical Picture, and Triggers of Allergic Rhinitis in Saudi Population: A Systematic Review and Meta-Analysis. Journal of Asthma and Allergy 15, pages 1831-1849.
Read now
Cristoforo Incorvaia, Bruna L. Gritti & Erminia Ridolo. (2018) The economic advantage of allergen immunotherapy over drug treatment in respiratory allergy. Journal of Medical Economics 21:6, pages 553-555.
Read now

Articles from other publishers (2)

Giovanni Passalacqua, Diego Bagnasco & Giorgio Walter Canonica. (2019) 30 years of sublingual immunotherapy. Allergy 75:5, pages 1107-1120.
Crossref
Abdulmohsin A. Almehizia, Reema K. AlEssa, Khalid M. Alwusaidi, Khalid A. Alzamil, Modhi AlJumah, Sarah Aljohani, Adel F. Almutairi & Mahmoud Salam. (2019) Allergic rhinitis: Disease characteristics and coping measures in Saudi Arabia. PLOS ONE 14:6, pages e0217182.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.